{
    "clinical_study": {
        "@rank": "63788", 
        "acronym": "IMPACT", 
        "arm_group": [
            {
                "arm_group_label": "Standard Care", 
                "arm_group_type": "No Intervention", 
                "description": "Participant will receive standard cancer care"
            }, 
            {
                "arm_group_label": "Nursing Intervention", 
                "arm_group_type": "Experimental", 
                "description": "Participants will receive 4 planned phone calls from nurse practitioners during their first 2 cycles of chemotherapy"
            }
        ], 
        "brief_summary": {
            "textblock": "The main purpose of this study is to examine changes in patient-reported symptoms during the\n      first two cycles of neoadjuvant or adjuvant chemotherapy for non-small cell lung cancer\n      (NSCLC) and colorectal cancer (CRC), among patients who receive standard care plus a\n      proactive nursing intervention relative to patients who receive standard care alone.\n      Interventions to improve symptom management and prevent urgent care needs in both the clinic\n      and hospital for patients receiving chemotherapy with curative intent are needed to enhance\n      the quality of cancer care."
        }, 
        "brief_title": "Improving Care After Chemotherapy", 
        "condition": [
            "Non-small Cell Lung Cancer", 
            "Colorectal Cancer"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Carcinoma, Non-Small-Cell Lung", 
                "Colorectal Neoplasms", 
                "Lung Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "-  Participants with NSCLC or CRC undergoing neoadjuvant or adjuvant chemotherapy will be\n           asked to fill out self-report questionnaires at their first chemotherapy administration\n           visit, in order to measure patient-reported symptoms, psychological distress, and\n           satisfaction with oncology care.\n\n        -  Participants will then be randomized into one of the two study groups: standard care\n           with proactive phone calls from nurse practitioners or standard care alone.\n\n        -  Participants assigned to the standard care group will be treated by their care team as\n           would any other cancer patient.\n\n        -  Participants assigned to the intervention group will receive four proactive phone calls\n           from nurse practitioners designed to discuss symptom burden and management.  Proactive\n           phone calls will occur 2-4 days after chemotherapy administration and 5-7 days after\n           chemotherapy administration, during cycles 1 and 2.\n\n        -  Participants will be asked to fill out the same set of questionnaires during their\n           second and third chemotherapy administration visits, to assess patient-reported\n           symptoms, psychological distress, and satisfaction with oncology care.\n\n        -  Medical records will be reviewed at 24-weeks following the first chemotherapy\n           administration visit, to evaluate frequency of urgent outpatient cancer center visits,\n           emergency department visits, and hospital admissions that occurred during the study\n           period."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Adult (age 18 or older)\n\n          -  Newly diagnosed stage I-III colorectal cancer or non-small-cell lung cancer\n\n          -  Scheduled to receive neoadjuvant chemotherapy (i.e. pre-surgical cancer-directed\n             therapy with curative intent) or adjuvant chemotherapy (i.e. post-surgical\n             cancer-directed therapy with curative intent)\n\n          -  Able to respond to questions in English\n\n        Exclusion Criteria:\n\n          -  Already received 1 or more cycles of chemotherapy for the current regimen\n\n          -  Unwilling or unable to participate in the study"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01944137", 
            "org_study_id": "13-258"
        }, 
        "intervention": {
            "arm_group_label": "Nursing Intervention", 
            "description": "Participants will receive 4 planned phone calls from nurse practitioners during their first 2 cycles of chemotherapy, in order to proactively monitor and address chemotherapy-related symptoms.", 
            "intervention_name": "Nursing Intervention", 
            "intervention_type": "Other"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "colonic neoplasms", 
            "Lung neoplasms", 
            "patient-centered nursing"
        ], 
        "lastchanged_date": "October 4, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Boston", 
                    "country": "United States", 
                    "state": "Massachusetts", 
                    "zip": "02114"
                }, 
                "name": "Massachusetts General Hospital"
            }, 
            "investigator": {
                "last_name": "Theresa McDonnell, ACN-BC", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Improving Care After Chemotherapy", 
        "overall_contact": {
            "email": "tmcdonnell@partners.org", 
            "last_name": "Theresa McDonnell, DNP, APRN-BC", 
            "phone": "617-726-2602"
        }, 
        "overall_contact_backup": {
            "email": "cemccarty@partners.org", 
            "last_name": "Caitlin E McCarty, BA"
        }, 
        "overall_official": {
            "affiliation": "Massachusetts General Hospital", 
            "last_name": "Theresa McDonnell, ACNP-BC", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change from baseline (i.e. first chemotherapy administration visit) in patient-reported symptoms as measured by the Memorial Symptom Assessment Scale-Short Form.", 
            "safety_issue": "No", 
            "time_frame": "At approximately 2-3 weeks and 4-6 weeks post-baseline"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01944137"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Massachusetts General Hospital", 
            "investigator_full_name": "Theresa McDonnell", 
            "investigator_title": "Principal Investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Change from baseline (i.e. first chemotherapy administration visit) in patient-reported psychological distress as measured by the Patient Health Questionnaire-4.", 
                "safety_issue": "No", 
                "time_frame": "Approximately 2-3 weeks and 4-6 weeks post-baseline"
            }, 
            {
                "measure": "Change from baseline (i.e. first chemotherapy administration visit) in patient-reported satisfaction with oncology care as measured by the Family Caregiver Satisfaction-patient scale", 
                "safety_issue": "No", 
                "time_frame": "Approximately 2-3 weeks and 4-6 weeks post-baseline"
            }, 
            {
                "measure": "Frequency of urgent outpatient Cancer Center visits, emergency department visits, and hospital admissions during six months post-baseline", 
                "safety_issue": "No", 
                "time_frame": "Approximately six months post-baseline"
            }
        ], 
        "source": "Massachusetts General Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Massachusetts General Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}